StockVS

The Gabelli Healthcare & Wellness Trust (GRX) 株式分析

金融サービス

The Gabelli Healthcare & Wellness Trust

$9.03

$-0.03 (-0.33%)

最終更新日: 2026年5月26日

株価推移

分析

企業概要

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc., and managed by Gabelli Funds, LLC, which operates by investing in public equity markets globally with a primary focus on companies within the healthcare sector. This entity functions within the Financial Services sector, specifically the Asset Management industry, distinguishing it from traditional operating companies by serving as a pooled investment vehicle rather than a direct producer of healthcare goods or services. The fund's scale is quantified by a market capitalization of $138.77M, while specific data regarding annual revenue and employee count is not disclosed in the available financial records. The market capitalization figure of $138.77M indicates a mid-sized fund structure within the broader asset management landscape, suggesting a niche focus that targets specific healthcare investment opportunities rather than broad market exposure typical of larger mutual funds or exchange-traded funds.

財務健全性

The financial statements for The Gabelli Healthcare & Wellness Trust do not disclose specific figures for revenue, net income, or EBITDA, presenting a scenario where the gap between reported revenue and net income cannot be calculated to reveal cost structures in the traditional manner found in operating company reports. Similarly, the fund does not report specific amounts for free cash flow, meaning that the concept of financial flexibility derived from cash generation from operations is not quantifiable through standard free cash flow metrics in this specific context. All three margin metrics—gross margin, operating margin, and profit margin—are reported at 0.0%, which indicates that the fund likely reports net asset value changes or distributions in a manner that does not generate conventional operating profit margins associated with commercial enterprises. The balance sheet data regarding total cash and total debt is not available, preventing a direct comparison to assess whether the fund's underlying assets are held conservatively or if the structure relies on significant leverage. Furthermore, the debt-to-equity ratio is not disclosed, and the current ratio is unavailable, rendering it impossible to evaluate short-term liquidity based on standard current assets divided by current liabilities. Return on Equity and Return on Assets are also listed as unavailable, which limits the ability to assess management effectiveness through traditional return metrics that measure how efficiently equity and total assets are utilized to generate profits.

バリュエーション評価

The valuation metrics for the fund include a trailing twelve-month P/E ratio of 61.47, whereas a forward P/E ratio is not available, implying that market expectations for future earnings growth relative to the current price cannot be projected using this specific metric. The price-to-book ratio is not disclosed, which prevents a direct assessment of whether the market is pricing the fund at a premium or discount relative to its net asset value per share. Alternative valuation measures such as the price-to-sales ratio and EV/EBITDA are also unavailable, suggesting that the valuation analysis must rely heavily on the earnings-based P/E multiple or dividend yield rather than sales or enterprise value multiples. The stock has traded within a 52-week range with a high of $10.05 and a low of $8.93, but without a specific current share price provided in the facts, the exact percentage deviation from these bounds cannot be calculated. The beta value is not available, making it impossible to quantify the fund's price volatility relative to the broader market movements or to determine if the asset acts as a hedge against market downturns.

Growth & Income

The fund does not provide specific data points for revenue growth or earnings growth year-over-year, preventing an analysis of whether earnings are expanding at a rate faster or slower than revenue in the traditional sense of operating businesses. However, the fund offers a dividend yield of 7.4%, and with a payout ratio of 440.0%, the income profile indicates that the dividend paid to shareholders exceeds the reported net income or distributable earnings available to common shareholders. A payout ratio of 440.0% is mathematically unsustainable if interpreted through the lens of a traditional operating company's earnings, as it implies that the fund is distributing more cash than its reported earnings, a characteristic common in closed-ended funds that utilize capital appreciation or other liquidity sources to fund dividends. Consequently, the overall growth and income profile is defined not by organic earnings expansion or sustainable payout ratios typical of public corporations, but by the unique distribution mechanics of a closed-ended equity mutual fund that prioritizes high current income yields over conventional earnings growth metrics.

同業他社比較

The Gabelli Healthcare & Wellness Trust (GRX) は資産運用業界で事業を展開しています。時価総額による最も近い同業他社との比較は以下の通りです:

企業名 ティッカー 時価総額 PER
The Gabelli Healthcare & Wellness Trust GRX $135.91M 60.2
BlackRock, Inc. BLK $167.25B 27.1
Blackstone Inc. BX $144.37B 30.3
Brookfield Corporation BN.TO $142.06B 89.6

資産運用業界の平均PERは28.6倍です。The Gabelli Healthcare & Wellness TrustのPERは60.2です。

この分析はAIによって生成されたものであり、情報提供のみを目的としています。投資アドバイスではありません。データは遅延または不正確な場合があります。投資判断を行う前に、必ずご自身で調査を行い、資格を持つファイナンシャルアドバイザーにご相談ください。

The Gabelli Healthcare & Wellness Trustについて

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

企業説明は英語で表示されています。

ウェブサイトを見る →

主要指標

時価総額
$135.91M
PER
60.20
52週高値
$10.05
52週安値
$8.90
平均出来高
24.39K
配当利回り
7.53%

データはYahoo Financeよりyfinance経由で提供。毎日更新。

企業情報

取引所
NYSE
United States